Michel Khrestchatisky, Ph.D
Affiliations: | Université de la Méditerranée, Marseille, Provence-Alpes-Côte d'Azur, France |
Google:
"Michel Khrestchatisky"Mean distance: 106866
Collaborators
Sign in to add collaborator| Yannick Marchalant | collaborator | 2010-2014 | Université de la Méditerranée |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pilat D, Paumier JM, García-González L, et al. (2022) MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of Neuroinflammation. 19: 65 |
| García-González L, Paumier JM, Louis L, et al. (2021) MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21727 |
| Baranger K, van Gijsel-Bonnello M, Stephan D, et al. (2019) Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
| Rivera S, García-González L, Khrestchatisky M, et al. (2019) Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences : Cmls |
| Paumier JM, Py NA, García-González L, et al. (2018) Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801076R |
| Baranger K, Giannoni P, Girard SD, et al. (2017) Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. Neuropharmacology |
| Girard SD, Virard I, Lacassagne E, et al. (2017) From Blood to Lesioned Brain: An In Vitro Study on Migration Mechanisms of Human Nasal Olfactory Stem Cells. Stem Cells International. 2017: 1478606 |
| van Gijsel-Bonnello M, Baranger K, Benech P, et al. (2017) Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine. Plos One. 12: e0175369 |
| Baranger K, Bonnet AE, Girard SD, et al. (2016) MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro. Frontiers in Molecular Neuroscience. 9: 163 |
| Baranger K, Khrestchatisky M, Rivera S. (2016) MT5-MMP, just a new APP processing proteinase in Alzheimer's disease? Journal of Neuroinflammation. 13: 167 |